291 related articles for article (PubMed ID: 35450430)
21. Cochlear Implantation in Neurofibromatosis Type 2-Related Schwannomatosis: Long-Term Hearing Outcomes.
Grenier B; Mosnier I; Ferrary E; Nguyen Y; Sterkers O; Kalamarides M; Lahlou G; Daoudi H
Otolaryngol Head Neck Surg; 2024 Jul; 171(1):218-230. PubMed ID: 38482961
[TBL] [Abstract][Full Text] [Related]
22. Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2-Associated Vestibular Schwannoma.
Dornhoffer JR; Haller T; Lohse CM; Driscoll CLW; Neff BA; Saoji A; Link MJ; Carlson ML
Otol Neurotol; 2023 Sep; 44(8):791-797. PubMed ID: 37464449
[TBL] [Abstract][Full Text] [Related]
23. [COCHLEAR IMPLANTATION FOR PATIENTS WITH CONSERVATIVELY TREATED VESTIBULAR SCHWANNOMA].
Stern Shavit S; Adelman C; Yehezkely Kaufmann M
Harefuah; 2023 Aug; 162(7):419-423. PubMed ID: 37561030
[TBL] [Abstract][Full Text] [Related]
24. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
[TBL] [Abstract][Full Text] [Related]
25. Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 Service.
Smith ME; Edmiston R; Trudel M; Freeman S; Stapleton E; Axon P; Donnelly N; Tysome JR; Bance M; Obholzer R; Jiang D; Mackeith S; Ramsden J; O'Driscoll M; Mawman D; Buttimore J; Nunn T; Humphries J; Evans DG; Lloyd SKW;
Otol Neurotol; 2022 Jun; 43(5):538-546. PubMed ID: 35213477
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma).
Arístegui M; Denia A
Otol Neurotol; 2005 Mar; 26(2):205-10. PubMed ID: 15793406
[TBL] [Abstract][Full Text] [Related]
27. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
28. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
[TBL] [Abstract][Full Text] [Related]
29. Cochlear implantation in children with cochlear nerve deficiency.
Vincenti V; Ormitti F; Ventura E; Guida M; Piccinini A; Pasanisi E
Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):912-7. PubMed ID: 24690223
[TBL] [Abstract][Full Text] [Related]
30. A new experience of auditory brainstem implantation in Malaysia.
Tang IP; Kevin Ng BH; Prepageran N; Donald Ngian SL; Albert Sii HW
Med J Malaysia; 2018 Oct; 73(5):347-348. PubMed ID: 30350824
[TBL] [Abstract][Full Text] [Related]
31. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2.
Seo S; Shen S; Ding AS; Creighton FX
Laryngoscope; 2024 Apr; 134(4):1847-1853. PubMed ID: 37698390
[TBL] [Abstract][Full Text] [Related]
33. Cochlear implantation concurrent with translabyrinthine acoustic neuroma resection.
Ahsan S; Telischi F; Hodges A; Balkany T
Laryngoscope; 2003 Mar; 113(3):472-4. PubMed ID: 12616199
[TBL] [Abstract][Full Text] [Related]
34. Hearing Rehabilitation in Patients With Neurofibromatosis Type 2: The Quebec's Experience With Auditory Implants.
Khneisser E; Bussieres R; Côté M; Philippon D; Fradet G; Côté M; Lessard N; Champagne PO; Trudel M
Otol Neurotol; 2023 Sep; 44(8):e621-e627. PubMed ID: 37550875
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous Translabyrinthine Tumor Removal and Cochlear Implantation in Vestibular Schwannoma Patients.
Kim JW; Han JH; Kim JW; Moon IS
Yonsei Med J; 2016 Nov; 57(6):1535-9. PubMed ID: 27593888
[TBL] [Abstract][Full Text] [Related]
36. Cochlear implants to treat deafness caused by vestibular schwannomas.
Mukherjee P; Ramsden JD; Donnelly N; Axon P; Saeed S; Fagan P; Irving RM
Otol Neurotol; 2013 Sep; 34(7):1291-8. PubMed ID: 23921933
[TBL] [Abstract][Full Text] [Related]
37. Auditory brainstem implants for neurofibromatosis type 2.
Colletti L; Shannon R; Colletti V
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
[TBL] [Abstract][Full Text] [Related]
38. Cochlear implant in vestibular schwannomas: long-term outcomes and critical analysis of indications.
Sorrentino F; Tealdo G; Cazzador D; Favaretto N; Brotto D; Montino S; Caserta E; Bovo R; Denaro L; Baro V; D'Avella D; Martini A; Mazzoni A; Marioni G; Zanoletti E
Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4709-4718. PubMed ID: 35018505
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis type 2: Hearing preservation and rehabilitation.
Jia H; El Sayed MME; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
Neurochirurgie; 2018 Nov; 64(5):348-354. PubMed ID: 30314805
[TBL] [Abstract][Full Text] [Related]
40. Cochlear implantation in patients with bilateral Ménière's syndrome.
Lustig LR; Yeagle J; Niparko JK; Minor LB
Otol Neurotol; 2003 May; 24(3):397-403. PubMed ID: 12806291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
